It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...

In the beginning, not even Hynek Wichterle's postdoc thought his idea to slow the progression of amyotrophic lateral ...

Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie's Quest, today announced plans to ...

Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to ...

Salym Liufau was at a family birthday party in 2022 when she squatted to pick up her kids, a motion she’d done a million ...

Brooke Eby posted a "dying diary" to describe the feeling of her ALS and progressing paralysis. The 36-year-old TikToker ...

The amyotrophic lateral sclerosis (ALS) treatment market was valued at USD 791.90 Million in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 5.40% from 2025 to 2034.

Amyotrophic Lateral Sclerosis, ALS, is a horrible disease. Last week in a reversal of a decision the FDA made just a few months ago, their external advisory board approved a “novel” drug for ALS. What ...

Safety & Health First Responder Class on Amyotrophic Lateral Sclerosis (ALS) This event is designed to help all first responders be better prepared when responding to a call involving someone with ALS ...

Amyotrophic Lateral Sclerosis Treatment Market Distribution Channel Insights Hospital pharmacies held a significant revenue share in the amyotrophic lateral sclerosis (ALS) treatment market in ...